Compounds > 2-chloroadenosine
Page last updated: 2024-08-20

2-chloroadenosine and Cancer of Prostate

2-chloroadenosine has been researched along with Cancer of Prostate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellezza, I; Minelli, A; Tucci, A1
Bellezza, I; Conte, C; Culig, Z; Minelli, A; Rambotti, MG; Tucci, A1
Agostini, M; Bellezza, I; Bracarda, S; Culig, Z; Minelli, A1
Bellezza, I; Bracarda, S; Conte, C; Culig, Z; Minelli, A; Tucci, A1

Reviews

1 review(s) available for 2-chloroadenosine and Cancer of Prostate

ArticleYear
2-Chloroadenosine and human prostate cancer cells.
    Anti-cancer agents in medicinal chemistry, 2008, Volume: 8, Issue:7

    Topics: 2-Chloroadenosine; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Gene Expression; Humans; Interleukin-23; Male; Molecular Structure; Prostatic Neoplasms; Receptor, PAR-1

2008

Other Studies

3 other study(ies) available for 2-chloroadenosine and Cancer of Prostate

ArticleYear
Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.
    The Prostate, 2009, Apr-01, Volume: 69, Issue:5

    Topics: 2-Chloroadenosine; Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Cladribine; Disease Models, Animal; Glutathione; Humans; Male; Mice; NF-E2-Related Factor 2; Nucleoside Transport Proteins; Prostatic Neoplasms; Purinergic P1 Receptor Agonists; Reactive Oxygen Species

2009
Mechanism of 2-chloroadenosine toxicity to PC3 cell line.
    The Prostate, 2006, Sep-15, Volume: 66, Issue:13

    Topics: 2-Chloroadenosine; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Damage; DNA, Neoplasm; Drug Screening Assays, Antitumor; Humans; Male; Prostatic Neoplasms

2006
2-chloroadenosine modulates PAR-1 and IL-23 expression and enhances docetaxel effects on PC3 cells.
    The Prostate, 2008, Mar-01, Volume: 68, Issue:4

    Topics: 2-Chloroadenosine; Agar; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Docetaxel; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Interleukin-23 Subunit p19; Male; Prostatic Neoplasms; Receptor, PAR-1; S Phase; Stem Cells; Taxoids

2008